Isolated islets in diabetes research

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 425-440

  Bhonde, Ramesh Ramchandra ^a   Shukla, R C ^a   Kanitkar, M ^a   Shukla, R ^a   Banerjee, M ^a   Datar, S ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Cytoprotection; Hypoglycaemics; Islets; Regeneration; Transplantation

Indexed keywords

3 AMINOBENZAMIDE; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ASCORBIC ACID; BELATACEPT; CHLORAMPHENICOL; EFAROXAN; ERYTHROMYCIN; GENTAMICIN; GLIBENCLAMIDE; GYMNEMA SYLVESTRE EXTRACT; METFORMIN; MITIGLINIDE; MITOMYCIN C; MOMORDICA CHARANTIA EXTRACT; NATEGLINIDE; NEOMYCIN; PENICILLIN G; PLANT EXTRACT; RECOMBINANT INTERLEUKIN 1BETA; SCOPARIA DULCIS EXTRACT; SILYMARIN; STREPTOMYCIN; TACROLIMUS; TETRACYCLINE; TEUCRIUM POLIUM EXTRACT; TINOSPORA CRISPA EXTRACT; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URTICA DIOICA EXTRACT;

ANTIOXIDANT ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; CYTOTOXICITY; DIABETES MELLITUS; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TINOSPORA; TINOSPORA CRISPA;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MODELS, BIOLOGICAL; RESEARCH;

EID: 34249292297     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Dittrich HM, Hahn von Dorsche H. The anatomical and histological investigation of the pancreas in the 19th century and pancreas research from discovery of islets (1869) till the discovery of pancreas -diabetes 1889. Anat Anz 1978; 143: 231-41.
2. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-20.
3. Shewade YM, Umrani M, Bhonde RR. Large-scale isolation of islets by tissue culture of adult mouse pancreas. Transplant Proc 1999; 31: 1721-3.
4. Bhonde RR, Parab PB, Sheorin VS. An in vitro model for screening oral hypoglycemics. In vitro Cell Dev Biol Anim 1999; 35: 366-8.
5. Noor H, Hammonds P, Sutton R, Ashcroft SJ. The hypoglycaemic and insulinotropic activity of Tinospora crispa: studies with human and rat islets and HIT-T15 B cells. Diabetologia 1989; 32: 354-9.
6. Persaud SJ, Al-Majed H, Raman A, Jones PM. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol 1999; 163: 207-12.
7. Sitasawad SJ, Shewade Y, Bhonde R. Role of bittergourd fruit juice in stz-induced diabetic state in vivo and in vitro. J Ethnopharmacol 2000; 73: 71-9.
8. Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani SH. Induction of insulin secretion by a component of Urtica dioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol 2003; 89: 47-53.
9. Latha M, Pari L, Sitasawad S, Bhonde R. Insulin-secretagogue activity and cytoprotective role of the traditional antidiabetic plant Scoparia dulcis (Sweet Broomweed). Life Sci 2004; 75: 2003-14.
10. Esmaeili MA, Yazdanparast R. Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets. J Ethnopharmacol 2004; 95: 27-30.
11. Jonas JC, Plant TD, Henquin JC. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic betacells. Br J Pharmacol 1992; 107: 8-14.
12. Giannaccini G, Lupi R, Trincavelli ML, Navalesi R, Betti L, Marchetti P, et al. Characterization of sulfonylurea receptors in isolated human pancreatic islets. J Cell Biochem 1998; 71: 182-8.
13. Masuda K, Okamoto Y, Tsuura Y, Kato S, Miura T, Tsuda K, et al. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Diabetologia 1995; 38: 24-30.
14. Tsukuda K, Sakurada M, Niki I, Oka Y, Kikuchi M. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine. Horm Metab Res 1998; 30: 42-9.
15. Louchami K, Jijakli H, Malaisse JW. Effect of the meglitinide analog S21403 on cationic fluxes and insulin release in perifused rat pancreatic islets exposed to a high concentration of D-glucose. Pharmacol Res 1999; 40: 297-300.
16. Mears D, Leighton X, Atwater RE. Tetracaine stimulates insulin secretion from the pancreatic beta-cell by release of intracellular calcium. Cell Calcium 1999; 25: 59-68.
17. Hashiguchi S, Yada T, Arima T. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide. J Pharmacol Exp Ther 2001; 296: 22-30.
18. Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes 1986; 35: 1049-52.
19. Robertson RP. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986; 35: 1016-9.
20. Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-TI5 cells and Wistar rat islets. Transplantation 2002; 73: 353-7.
21. Uchizono Y, Iwase M, Nakamura U, Sasaki N, Goto D, Iida M. Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 2004; 145: 2264-72.
22. Pou JM, Cervera T, Perez A, Ortiz MA, Arroyo JA. Effect of L-asparaginase on insulin secretion from isolated rat islets of Langerhans. Horm Res 1991; 35: 155-60.
23. Metz SA, Rabaglia ME, Pintar TJ. Selective inhibitors of GTP synthesis impede exocytotic insulin release from intact rat islets. J Biol Chem 1992; 267: 12517-27.
24. Sandstrom PE. Inhibition by hydrochlorothiazide of insulin release and calcium influx in mouse pancreatic beta-cells. Br J Pharmacol 1993; 110: 1359-62.
25. Patane G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purrello F. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 2000; 49: 735-40.
26. Marchetti P, Guerra S, Marselli L, Lupi R, Masini M, Pollera M. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89: 5535-41.
27. Leclerc I, Woltersdorf WW, Xavier GS, Rowe RL, Cross SE, Korbutt GS. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: E1023-31.
28. Shewade Y, Tirth S, Bhonde RR. Pancreatic islet-cell viability, functionality and oxidative status remain unaffected at pharmacological concentrations of commonly used antibiotics in vitro. J Biosci 2001; 26: 349-55.
29. Dudeck NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E, et al. Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 2006; 55: 2412-8.
30. Burkart V, Blaeser K, Kolb H. Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor. Horm Metab Res 1999; 31: 641-4.
31. Mandrup-Poulsen T. Beta cell death and protection. Ann NY Acad Sci 2003; 1005: 32-42.
32. Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S. Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through over-expression of antioxidant enzymes. Diabetes 2000; 49: 1123-30.
33. Tran PO, Parker SM, LeRoy E, Franklin CC, Kavanagh TJ, Zhang T. Adenoviral over-expression of the glutamylcysteine ligase catalytic subunit protects pancreatic islets against oxidative stress. J Biol Chem 2004; 279: 53988-93.
34. Kaneto H, Fujii J, Seo H, Suzuki K, Matsuoka T, Nakamura M. Apoptotic cell death triggered by Nitric oxide in pancreatic β-cells. Diabetes 1995; 44: 733-8.
35. Mabley JG, Southan GJ, Salzman AL, Szabo C. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro. Pancreas 2004; 28: E39-44.
36. Papaccio G, Graziano A, Valiante S, D'Aquino R, Travali S, Nicoletti F. Interleukin (IL)-1beta toxicity to islet beta cells: Efaroxan exerts a complete protection. J Cell Physiol 2005; 203: 94-102.
37. Szabo C, Mabely JG, Moeller SM, Shimanovich R, Pacher P, Virag L, et al. Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel peroxynitrite decomposition catalyst. Mol Med 2002; 8: 571-80.
38. Matsuda T, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F, et al. Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology 2005; 146: 175-85.
39. Garg M, Bansal D. Protective antioxidant effects of vitamins C and E in streptozotocin induced diabetic rats. Indian J Exp Biol 2000; 38: 101-4.
40. Latha M, Pari L, Sitasawad S, Bhonde R. Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo. J Biochem Mol Toxicol 2004; 18: 261-72.
41. Srivivasan A, Menon VP, Periaswamy V, Rajasekaran KN. Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 2003; 6: 327-33.
42. Lee SH, Han YM, Min YM, Park IS., Cytoprotective effects of polyenoylohosphatidylcholine (PPQ on beta cells during diabetic induction by streptozotocin. J Histochem Cytochem 2003; 51: 1005-15.
43. Burkart V, Wand Z, Radons J, Heller B, Herceg Z, Stingl L, et al. Mice lacking the poly (ADP ribose) polymerase gene are resistant to pancreatic beta cell destruction and diabetes development induced by streptozotocin. Nat Med 1999; 5: 314-9.
44. Mabely J, Suarez-Pinzon W, Hasko G, Salzmann AL, Rabinovich A, Kun E. Inhibition of poly (ADP - ribose)synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2 benzopyrone protects mice from multiple-low-dose- streptozotocin induced diabetes. Br J Pharmacol 2001; 133: 909-19.
45. Baeuerle P, Baltimore D. NF-kB: ten years after. Cell 1996; 87: 13-20.
46. Yamamoto Y, Gaynor R. IêK Kinases: key regulators of the NFkB pathway. Trends Biochem Sci 2003; 29: 72-9.
47. Lgssiar A, Hassan M, Schott-Ohly P, Freisen N, Nicoleti F, Trepicchi W, et al. Interleukin 11 inhibits NFkB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice. Exp Biol Med (Maywood) 2004; 229: 425-36.
48. Rehman K, Bertera S, Bottino R, Balamurugan A, Mai J, Mi Z, et al. Protection of islets by in situ peptide mediated transduction of the IkB kinase inhibitor Nemo binding domain peptide. J Biol Chem 2003; 278: 9862-8.
49. Wu LP, Chen LH, Zhang JS, Sun L, Zhang YQ. Protective effect of rhIL-1beta on pancreatic islets of alloxan-induced diabetic rats. World J Gastroenterol 2004; 10: 3353-5.
50. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Perego C, et al. High glucose apoptosis in cultured human pancreatic islets of Langerhans: A potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001; 50: 1290-301.
51. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka H, Spinas G, et al. Glucose induced β cell production of IL-1 β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851-60.
52. El-Assad W, Buteau J, Peyot M, Nolan C, Roduit R, Hardy S, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta cell death. Endocrinology 2003; 144: 4154-63.
53. Piro S, Anello M, Di Pietro C, Lizzio N, Patane G, Rabauazzo A, et al. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 2002; 51: 1340-7.
54. Kawasaki E, Abiru N, Eguchi K. Prevention of Type 1 diabetes: from the viewpoint of beta cell damage. Diabetes Res Clin Pract 2004; 66 (Suppl 1): 27-32.
55. Weir GC, Bonner-Weir S. Scientific and political impediments to successful islet transplantation. Diabetes 1997; 46: 1247-56.
56. Sutherland DE, Goetz FC, Chinn PL, Elick BA, Najarian JS. Pancreas transplantation. Pediatr Clin North Am 1984; 31: 735-50.
57. Ricordi C. Islet transplantation: a brave new world. Diabetes 2003; 52: 1595-603.
58. Robertson RP. Islet transplantation as a treatment for diabetes- A work in progress. N Engl J Med 2004; 350: 694-705.
59. Hayashi H, Inoue K, Aung T, Tun T, Yuanjun G, Wenjing W, et al. Application of a novel b cell line MIN6 to a mesh-reinforced polyvinyl alcohol hydrogel tube and three-layer agarose microcapsules: an in vitro study. Cell Transplant 1996; 5 (5 Suppl 1): S65-9.
60. Ohgawara H, Miyazaki J, Nakagawa Y, Sato S, Karibe S, Akaike T. Xenoimplantation using a diffusion chamber with a β-cell line (MIN6) as a bioartificial endocrine pancreas (Bio-AEP). Cell Transplant 1996; 5 (5 Suppl 1): S71-3.
61. Spinas GA, Mandrup-Poulsen T, Molvig J, Baek L, Bendtzen K, Dinarello CA, et al. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol (Copenh) 1986; 113: 551-8.
62. Lee I, Wang L, Wells AD, Ye Q, Han R, Dorf ME, et al. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol 2003; 171: 6929-35.
63. Fenjves ES, Ochoa MS, Gay-Rabinstein C, Molano RD, Pileggi A, Mendez AJ. Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets. Transplantation 2004; 77: 13-8.
64. Riachy R, Vandewalle B, Kerr Conte J, Moerman E, Sacchetti P, Lukowiak B, et al. 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 2002; 143: 4809-19.
65. Contreras JL, Bilbao G, Smyth CA, Jiang XL, Eckhoff DE, Jenkins SM, et al. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene. Transplantation 2001; 71: 1615-23.
66. Ferber S, Heimberg H, Brownlee M, Colton C. Surrogate beta cells. Diabetologia 1997; 40 (Suppl 3): B39-43.
67. Ranuncoli A, Cautero N, Ricordi C, Masetti M, Molano RD, Inverardi L. Islet cell transplantation: in vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 2000; 9: 409-14.
68. Cotterell AA, Kenyon NS. Alternatives to immunosuppressive drugs in human islet transplantation. Curr Diab Rep 2002; 2: 377-82.
69. Oluwole OO, Depaz HA, Gopinathan R, Ali A, Garrovillo M, Jin MX. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 2001; 50: 1546-52.
70. Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes 2004; 53: 376-83.
71. Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabeck L, Burge M, et al. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 2003; 52: 59-68.
72. Seung E, Iwakoshi N, Woda BN, Markees TG, Mordes JP, Rossinni AA, et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoinummity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175-82.
73. Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 1996; 156: 380-8.
74. Kaufman CL, Li H, Ildstad ST. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. J Immunol 1997; 158: 2435-42.
75. Liang Y, Huang T, Zhang C, Todorov I, Atkinson M, Kandeel F. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood 2005; 105: 2180-8.
76. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233-58.
77. Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, Rees P, et al. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogenic islets in non-human primates. Diabetes 2002; 51: 265-70.
78. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, et al. Allogeneic bone marrow transplantation with costimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464-9.
79. Seung E, Mordes JP, Rossini AA, Greiner DL. Hematopoietic chimerism. and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J Clin Invest 2003; 112: 795-808.
80. Pearson T, Weiser P, Markees TG, Serreze DV, Wicker LS, Peterson LB. Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3. Diabetes 2004; 53: 1972-8.
81. Gotoh M, Sato Y, Abe T, Kanazawa Y. New approaches for successful islet transplantation. J Hepatobiliary Pancreat Surg 2000; 7: 358-63.
82. Ricordi C, Scharp DW, Lacy PE. Reversal of diabetes in nude mice after transplantation offresh and 7-day-cultured (24°C) human pancreatic islets. Transplantation 1988; 45: 994-6.
83. Stein E, Mullen Y, Benhamou PY, Watt PC, Hober C, Watanabe Y. Reduction in immunogenicity of human islets by 24 degrees C culture. Transplant Proc 1994; 26: 755.
84. Benhamou PY, Stein E, Hober C, Miyamoto M, Watanabe Y, Nomura Y. Ultraviolet light irradiation reduces human islet immunogenicity without altering islet function. Horm Metab Res 1995; 27: 113-20.
85. Miyamoto M, Kenmochi T, Nakagawa Y, Une S, Moldovan S, Atiya A. Immunogenicity of cryopreserved human islets. Transplant Proc 1995; 27: 3406-8.
86. Hardikar AA, Risbud MV, Remacle C, Reusens B, Hoet JJ, Bhonde RR. Islet cryopreservation: improved recovery following taurine pretreatment. Cell Transplant 2001; 10: 247-53.
87. Grtochowiecki T, Gotoh M, Dono K, Takeda Y, Nishihara M, Ohta Y. Pretreatment of crude pancreatic islets with mitomycin C prolongs graft survival time in xenogeneic rat-to-mouse model. Transplantation 1999; 67: 1474-7.
88. Zeng Y, Gage A, Montag A, Rothlein R, Thistlethwaite JR, Bluestone JA. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation 1994; 58: 681-9.
89. Takeda Y, Gotoh M, Dono K, Nishihara M, Grochowiecki T, Kimura F. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Diabetologia 1998; 41: 315-21.
90. Weir GC, Quickel RR, Yoon KH, Tatarkiewicz K, Ulrich TR, Hollister-Lock J., et al. Porcine neonatal pancreatic cell clusters (NPCCs): a potential source of tissue for islet transplantation. Ann Transplant 1997; 2: 63-8.
91. Ricordi C, Socci C, Davalli AM, Staudacher C, Vertova A, Baro P., et al. Swine islet isolation and transplantation. Horm Metab Res Suppl. 1990; 25: 26-30.
92. Garkavenko O, Croxson MC, Irgang M, Karlas A, Denner J, Elliott RB. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42: 5353-6.
93. Noel J, Rabinovitch A, Olson L, Kyriakides G, Miller J, Mintz DH. A method for large-scale, high-yield isolation of canine pancreatic islets of Langerhans. Metabolism 1982; 31: 184-7.
94. Lanza RP, Buder DH, Borland KM, Harvey JM, Faustman DL, Solomon BA, et al. Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: a study using canine, bovine, and porcine islets. Transplant Proc 1992; 24: 669-71.
95. Eloy R, Haffen K, Kedinger M, Grenier JF. Chick embryo pancreatic transplants reverse experimental diabetes of rats. J Clin Invest 1979; 64: 361-73.
96. Giannarelli R, Marchetti P, Bianchi F, Villani G, Cruschelli L, Bernardini N, et al. Isolation of islets of Langerhans from the chicken pancreas. Transplant Proc 1994; 26: 1127-9.
97. Coddington DA, Lawen JG, Yang H, O'Hali W, Wright JR. Xenotransplantation of fish islets into the non-cryptorchid testis. Transplant Proc 1997; 29: 2083-5.
98. O'Hali W, Yang H, Pohajdak B, La Prairie A, Gross M, Wright JR. Cryopreservation of principal islets of teleost fish: the effect on function and islet xenograft survival. Transplant Proc 1997; 29: 1990-1.
99. Sun YL, Ma X, Zhou D, Vacek I, Sun AM. Porcine pancreatic islets: isolation, microencapsulation, and xenotransplantation. Artif Organs 1993; 17: 727-33.
100. O'Shea GM, Goosen MF, Sun AM. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 1984; 804: 133-6.
101. Tatarkiewicz K, Sitarek E, Sabat M, Orlowski T. Reversal of hyperglycemia in streptozotocin diabetic mice by xenotransplantation of microencapsulated rat islets. Ann Transplant 1997; 2: 20-3.
102. Lim F, Sun AM. Microencapsulated islets as bioartificial pancreas. Science 1980; 210: 908-10.
103. Krestow M, Lum ZP, Tai IT, Sun A. Xenotransplantation of microencapsulated fetal rat islets. Transplantation 1991; 51: 651-5.
104. Cochrum K, Jemtrud S, Dorian R. Successful xenografts in mice with microencapsulated rat and dog islets. Transplant Proc 1995; 27: 3297-4201.
105. Balamurugan AN, Remington EJ, Ramakrishna B, Gunasekaran S. Xenographic survival and function of transplanted monkey pancreatic islets in rats. Transplant Proc 2000; 32: 1068-70.
106. Hamaguchi K, Tatsumoto N, Fujii S, Okeda T, Nakamura M, Yamaguchi K, Microencapsulation of pancreatic islets. A technique and its application to culture and transplantation. Diabetes Res Clin Pract 1986; 2: 337-45.
107. Hamelmann W, Ozasa T, Cairns T, Welsh K, Gray DW. Xenotransplantation of islets across a strong species barrier rabbit to cynomolgus monkey. Transplant Proc 1994; 26: 1097-9.
108. Risbud MV, Bhonde RR. Islet immunoisolation: experience with biopolymers. J Biomater Sci Polym Ed 2001; 12: 1243-52.
109. Risbud MV, Bhargava S, Bhonde RR. In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: Implications of low molecular weight cut-off. J Biomed Mater Res 2003; 66: 86-92.
110. Risbud MV, Bhonde RR. Suitability of cellulose molecular dialysis membrane for bioartificial pancreas: in vitro biocompatibility studies. J Biomed Mater Res 2001; 54: 436-44.
111. George S, Nair PD, Risbud MV, Bhonde RR. Nonporous polyurethane membranes as islet immunoisolation matrices-biocompatibility studies. J Biomater Appl 2002; 16: 327-40.
112. Risbud MV, Bhonde MR, Bhonde RR. Effect of chitosanpolyvinyl pyrrolidone hydrogel on proliferation and cytokine expression of endothelial cells: implications in islet immunoisolation. J Biomed Mater Res 2001; 57: 300-5.
113. Hardikar AA, Risbud MV, Bhonde RR. A simple microcapsule generator for islet encapsulation. J Biosci 1999; 24: 371-6.
114. Charles K, Harland RC, Ching D, Opara EC. Storage and microencapsulation of islets for transplantation. Cell Transplant 2000; 9: 33-8.
115. Yang H, O'Hali W, Kearns H, Wright JR. Long-term function of fish islet xenografts in mice by alginate encapsulation. Transplantation 1997; 64: 28-32.
116. Iwata H, Kobayashi K, Takagi T, Oka T, Yang H, Amemiya H, et al. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J Biomed Mater Res 1994; 28: 1003-11.
117. Lhommeau C, Toillon S, Pith T, Kessler L, Jesser C, Pinget M. Polyamide 4, 6 membranes for the encapsulation of Langerhans islets: preparation, physico-chemical properties and biocompatibility studies. J Mater Sci Mater Med 1997; 8: 163-74.
118. Cruise GM, Hegre OD, Lamberti FV, Hager SR, Hill R, Scharp DS, et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly (ethylene glycol) diacrylate membranes. Cell Transplant 1999; 8: 293-306.
119. Zekorn T, Siebers U, Filip L, Mauer K, Schmitt U, Bretzel RG, et al. Bioartificial pancreas: the use of different hollow fibers as a diffusion chamber. Transplant Proc 1989; 21: 2748-50.
120. Prevost P, Flori S, Collier C, Muscat E, Rolland E. Application of AN69 hydrogel to islet encapsulation. Evaluation in streptozotocin-induced diabetic rat model. Ann NY Acad Sci 1997; 831: 344-9.
121. Soldani G, Giusti P, Marchetti P. Polyurethrane-Polydimethylsiloxane (PU-PDMS) tubular membranes for pancreatic islet transplantation: perm selectivity and diffusion studies. J Mater Sci Mater Med 1992; 3: 371-6.
122. Zondervan GJ, Hoppen HJ, Permings AJ, Fritschy W, Wolters G, Van Schilfgaarde R. Design of a polyurethane membrane for the encapsulation of islets of Langerhans. Biomaterials 1992; 13: 136-44.
123. Bonner-Weir S. Two pathways of beta-cell growth in the regenerating rat pancreas: Implications for islet transplantation. Diabetes Nutr Metab 1992; 5: 1-3.
124. Bonner-Weir S. Perspective: postnatal pancreatic β cell growth. Endocrinology 2000; 141: 1926-9.
125. Rosenberg L. Induction of islet cell neogenesis in the adult pancreas: the partial duct obstruction model. Microsc Res Tech 1998; 43: 337-46.
126. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nature Med 2000; 6: 278-82.
127. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000; 97: 7999-8004.
128. Katdare MR, Bhonde RR, Parab PB. Analysis of morphological and functional maturation of neoislets generated in vitro from pancreatic ductal cells and their suitability for islet banking and transplantation. J Endocrinol 2004; 182: 105-12.
129. Banerjee M, Bhonde R. Islet generation from intra islet precursor cells of diabetic pancreas: in vitro studies depicting in vivo differentiation. JOP 2003; 4: 137-45.
130. Kanitkar M, Bhonde R. Existence of islet regenerating factors within the pancreas. Rev Diab Stud 2004; 1: 185-92.
131. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-6.
132. Swenne I. Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 1992; 35: 193-201.
133. Smith FS, Rosen KM, Villa-Komaro L., Weir GC, Bonner-Weir S. Enhanced insulin-like growth factor I gene expression in the regenerating rat pancreas. Proc Natl Acad Sci USA 1991; 88: 6152-6.
134. Hardikar AA, Bhonde RR. Modulating experimental diabetes by treatment with cytosolic extract from the regenerating pancreas. Diabetes Res Clin Pract 1999; 46: 203-11.
135. Swenne L, Andersson A. Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 1984; 27: 464-7.
136. Sjoholm A. Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Diabetes 1997; 46: 1141-7.
137. Movassat J, Beattie GM, Lopez AD, Portha B, Hayek A. Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia 2003; 46: 822-9.
138. Oberg-Welsh C, Sandler S, Andersson A, Welsh M. Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro. Mol Cell Endocrinol 1997; 126: 125-32.
139. Meneur C, Elghazi L, Czernichow P, Scharfmann R. Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes 2001; 50: 1571-9.
140. Sjoholm A, Welsh N, Hellerstrom C. Lithium increases DNA replication, polyamine content, and insulin secretion by rat pancreatic beta-cells. Am J Physiol 1992; 262: C 391-5.
141. King DL, Kitchen KC, Chick WL. Pancreatic beta-cell replication: relation to insulin secretion. Endocrinology 1978; 103: 1321-7.
142. Movassat J, Portha B. Beta-cell growth in the neonatal Goto-kakisaki rat and regeneration after treatment with streptozotocin at birth. Diabetologia 1999; 42: 1098-106.
143. Binette TM, Dufour JM, Korbutt GS. In vitro maturation of neonatal porcine islets: a novel model for the study of islet development and xenotransplantation. Ann NY Acad Sci 2001; 944: 47-61.
144. Welsh M, Anneren C, Lindholm C, Kriz V, Oberg-Welsh C. Role of tyrosine kinase signaling for beta-cell replication and survival. Ups J Med Sci 2000; 105: 7-15.
145. Kobinger GP, Deng S, Louboutin JP, Vatamaniuk M, Rivera VM, Lian MM, et al. Pharmacologically regulated regeneration of functional human pancreatic islets. Mol Ther 2005; 11: 105-11.